Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Aug;94(4):1175–1183. doi: 10.1111/j.1476-5381.1988.tb11636.x

Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.

K Ito 1, T Nakashima 1, K Murakami 1, T Murakami 1
PMCID: PMC1854079  PMID: 3145089

Abstract

1. Based on the findings in the preceding paper we investigated the ability of pulmonary endothelial cells to metabolize prostaglandin F2 alpha (PGF2 alpha) and angiotensin I (AI), and to produce endothelium-derived relaxing factor (EDRF) following lung vascular injury induced by monocrotaline in rats. The isometric tension of pulmonary artery rings isolated from rats 3-5 weeks after an injection of monocrotaline or saline was measured. For comparison the responses to drugs of the artery denuded of endothelium by rubbing were tested. 2. Acetylcholine-induced relaxation of the rings precontracted by noradrenaline was diminished in the artery from monocrotaline-treated rats, depending on the duration after treatment. The diminution was comparable to that in the control artery denuded of endothelium. 3. The contractile response to PGF2 alpha was significantly augmented in the artery injured by monocrotaline. The similar augmentation was observed after the mechanical removal of endothelium in the control artery. Decrease of EDRF was not involved in the enhancement of contractile response to PGF2 alpha in the monocrotaline-injured artery. 4. AI caused a contraction, which was sensitive to captopril, in control rings, and also in monocrotaline-injured rings to a similar degree. Removal of endothelium from the control artery did not modify the response to AI or to AII. 5. These results suggest that the monocrotaline treatment of rats suppresses the ability of pulmonary endothelium to produce EDRF and to degrade prostaglandins. The relative resistance of the AI response to endothelial injury suggests that the existence of converting enzyme is not restricted to the endothelium.

Full text

PDF
1181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali A. E., Barrett J. C., Eling T. E. Prostaglandin and thromboxane production by fibroblasts and vascular endothelial cells. Prostaglandins. 1980 Oct;20(4):667–688. doi: 10.1016/0090-6980(80)90107-0. [DOI] [PubMed] [Google Scholar]
  2. Altiere R. J., Olson J. W., Gillespie M. N. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther. 1986 Feb;236(2):390–395. [PubMed] [Google Scholar]
  3. Bakhle Y. S., Vane J. R. Pharmacokinetic function of the pulmonary circulation. Physiol Rev. 1974 Oct;54(4):1007–1045. doi: 10.1152/physrev.1974.54.4.1007. [DOI] [PubMed] [Google Scholar]
  4. Caldwell P. R., Seegal B. C., Hsu K. C., Das M., Soffer R. L. Angiotensin-converting enzyme: vascular endothelial localization. Science. 1976 Mar 12;191(4231):1050–1051. doi: 10.1126/science.175444. [DOI] [PubMed] [Google Scholar]
  5. Chand N., Altura B. M. Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science. 1981 Sep 18;213(4514):1376–1379. doi: 10.1126/science.7268440. [DOI] [PubMed] [Google Scholar]
  6. D'Orléans-Juste P., Dion S., Mizrahi J., Regoli D. Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol. 1985 Aug 7;114(1):9–21. doi: 10.1016/0014-2999(85)90515-1. [DOI] [PubMed] [Google Scholar]
  7. Furchgott R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol. 1984;24:175–197. doi: 10.1146/annurev.pa.24.040184.001135. [DOI] [PubMed] [Google Scholar]
  8. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  9. Ghodsi F., Will J. A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol. 1981 Feb;240(2):H149–H155. doi: 10.1152/ajpheart.1981.240.2.H149. [DOI] [PubMed] [Google Scholar]
  10. Gillespie M. N., Olson J. W., Reinsel C. N., O'Connor W. N., Altiere R. J. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats. Am J Physiol. 1986 Jul;251(1 Pt 2):H109–H114. doi: 10.1152/ajpheart.1986.251.1.H109. [DOI] [PubMed] [Google Scholar]
  11. Griffith T. M., Henderson A. H., Edwards D. H., Lewis M. J. Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor. J Physiol. 1984 Jun;351:13–24. doi: 10.1113/jphysiol.1984.sp015228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gryglewski R. J., Korbut R., Ocetkiewicz A. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature. 1978 Jun 29;273(5665):765–767. doi: 10.1038/273765a0. [DOI] [PubMed] [Google Scholar]
  13. Hilliker K. S., Bell T. G., Roth R. A. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am J Physiol. 1982 Apr;242(4):H573–H579. doi: 10.1152/ajpheart.1982.242.4.H573. [DOI] [PubMed] [Google Scholar]
  14. Hilliker K. S., Roth R. A. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole. Am Rev Respir Dis. 1985 Jan;131(1):46–50. doi: 10.1164/arrd.1985.131.1.46. [DOI] [PubMed] [Google Scholar]
  15. Ito K., Hayashi K., Nakashima T., Murakami T. Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats. Br J Pharmacol. 1988 Aug;94(4):1167–1174. doi: 10.1111/j.1476-5381.1988.tb11635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kay J. M., Keane P. M., Suyama K. L., Gauthier D. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension. Thorax. 1982 Feb;37(2):88–96. doi: 10.1136/thx.37.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Martin W., Furchgott R. F., Villani G. M., Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1986 May;237(2):529–538. [PubMed] [Google Scholar]
  18. Meyrick B., Gamble W., Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol. 1980 Nov;239(5):H692–H702. doi: 10.1152/ajpheart.1980.239.5.H692. [DOI] [PubMed] [Google Scholar]
  19. Moncada S., Korbut R., Bunting S., Vane J. R. Prostacyclin is a circulating hormone. Nature. 1978 Jun 29;273(5665):767–768. doi: 10.1038/273767a0. [DOI] [PubMed] [Google Scholar]
  20. Ody C., Dieterle Y., Wand I., Stalder H., Junod A. F. PGA1 and PGF2 alpha metabolism by pig pulmonary endothelium, smooth muscle, and fibroblasts. J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):211–216. doi: 10.1152/jappl.1979.46.2.211. [DOI] [PubMed] [Google Scholar]
  21. Ryan U. S. Metabolic activity of pulmonary endothelium: modulations of structure and function. Annu Rev Physiol. 1986;48:263–277. doi: 10.1146/annurev.ph.48.030186.001403. [DOI] [PubMed] [Google Scholar]
  22. Ryan U. S., Ryan J. W., Whitaker C., Chiu A. Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell. 1976;8(1):125–145. doi: 10.1016/0040-8166(76)90025-2. [DOI] [PubMed] [Google Scholar]
  23. Said S. I. Metabolic functions of the pulmonary circulation. Circ Res. 1982 Mar;50(3):325–333. doi: 10.1161/01.res.50.3.325. [DOI] [PubMed] [Google Scholar]
  24. Schrör K. Prostaglandins, other eicosanoids and endothelial cells. Basic Res Cardiol. 1985 Sep-Oct;80(5):502–514. doi: 10.1007/BF01907914. [DOI] [PubMed] [Google Scholar]
  25. Toda N., Miyazaki M. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol. 1981 Feb;240(2):H247–H254. doi: 10.1152/ajpheart.1981.240.2.H247. [DOI] [PubMed] [Google Scholar]
  26. Vanhoutte P. M., Rubanyi G. M., Miller V. M., Houston D. S. Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol. 1986;48:307–320. doi: 10.1146/annurev.ph.48.030186.001515. [DOI] [PubMed] [Google Scholar]
  27. Velletri P., Bean B. L. The effects of captopril on rat aortic angiotensin-converting enzyme. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):315–325. doi: 10.1097/00005344-198203000-00022. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES